Ob/Gyn & Women's Health

Years after clinicians started reporting data on care provided to patients with depression, metrics used to score quality are the focus of new scrutiny.

This is one time when being at the top of the food chain is not advantageous.

Recently, the FDA approved the first OTC continuous glucose monitors. Beverly Tchang, MD, shares how these can be an important step toward personalized medicine.

A 50-year-old man with a history of colon cancer and GERD presents to the ED with chest pain that radiates to his jaw and arm. He started chemotherapy a few days ago. What's causing his symptoms?

Researchers say a test meant to measure risk for opioid use disorder may cause harm. Their arguments are part of a larger debate about using genetic information to guide clinical care.